Strategi Pencegahan Penyalahgunaan Narkotika Melalui Collaborative Governance pada LRPPN-BI Kabupaten Banyuwangi
DOI:
https://doi.org/10.47134/pssh.v1i2.120Keywords:
Strategi, Penyalahgunaan narkotika, Collaborative governannceAbstract
Penelitian ini membahas mengenai strategi LRPPN-BI Kabupaten Banyuwangi dalam menurunkan angka penyalahgunaan narkotika melalui kerja sama dengan instansi pemerintah maupun swasta. Lembaga Rehabilitasi Pencegahan Penyalahgunaan Narkotika Bhayangkara Indonesia (LRPPN-BI) Kabupaten Banyuwangi melakukan sosialisasi dan penyuluhan terkait bahaya narkotika dengan tujuan meningkatkan pemahaman dan wawasan akan bahaya narkotika serta menyelamatkan generasi milenial Banyuwangi dari penyalahgunaan narkotika. Alasan pelaksanaan strategi ini yaitu mengingat angka penyalahgunaan narkotika yang semakin meningkat tiap tahunnya di Banyuwangi dan mirisnya korban penyalahgunaan narkotika paling banyak berasal dari remaja sekolah. Penelitian ini dilakukan dengan menggunakan pendekatan deskriptif kualitatif, dengan metode pengumpulan data berupa wawancara kepada beberapa narasumber dengan menggunakan teknik purposive sampling. Hasil penelitian ini menunjukkan bahwa Lembaga Rehabilitasi Pencegahan Penyalahgunaan Narkotika Bhayangkara Indonesia Kabupaten Banyuwangi dalam melaksanakan strategi pencegahan narkotika dinilai sudah baik. Hal ini dapat dilihat dari adanya kolaborasi pihak internal maupun eksternal dalam membantu pelaksanaan strategi sudah berjalan sesuai dengan yang diharapkan sehingga menghasilkan sinergi yang baik dalam implementasi strategi. Meski memiliki keterbatasan anggaran, pelaksanaan strategi melalui sosialisasi dan penyuluhan ini sudah dilaksanakan hampir di seluruh Kabupaten Banyuwangi.
References
Bazzi, A. R. (2018). Limited Knowledge and Mixed Interest in Pre-Exposure Prophylaxis for HIV Prevention among People Who Inject Drugs. AIDS Patient Care and STDs, 32(12), 529–537. https://doi.org/10.1089/apc.2018.0126
Chhikara, B. S. (2020). Corona virus SARS-CoV-2 disease COVID-19: Infection, prevention and clinical advances of the prospective chemical drug therapeutics. Chemical Biology Letters, 7(1), 63–72.
Daudon, M. (2018). Drug-Induced Kidney Stones and Crystalline Nephropathy: Pathophysiology, Prevention and Treatment. Drugs, 78(2), 163–201. https://doi.org/10.1007/s40265-017-0853-7
Dubberke, E. R. (2018). Results from a Randomized, Placebo-Controlled Clinical Trial of a RBX2660 - A Microbiota-Based Drug for the Prevention of Recurrent Clostridium difficile Infection. Clinical Infectious Diseases, 67(8), 1198–1204. https://doi.org/10.1093/cid/ciy259
Farah, S. (2019). Long-term implant fibrosis prevention in rodents and non-human primates using crystallized drug formulations. Nature Materials, 18(8), 892–904. https://doi.org/10.1038/s41563-019-0377-5
Fink, H. A. (2019). Long-term drug therapy and drug discontinuations and holidays for osteoporosis fracture prevention: A Systematic Review. Annals of Internal Medicine, 171(1), 37–50. https://doi.org/10.7326/M19-0533
Fraser, H. (2018). Model projections on the impact of HCV treatment in the prevention of HCV transmission among people who inject drugs in Europe. Journal of Hepatology, 68(3), 402–411. https://doi.org/10.1016/j.jhep.2017.10.010
Gonzalez-Cuevas, G. (2018). Unique treatment potential of cannabidiol for the prevention of relapse to drug use: preclinical proof of principle. Neuropsychopharmacology, 43(10), 2036–2045. https://doi.org/10.1038/s41386-018-0050-8
Gulick, R. M. (2019). Long-acting HIV drugs for treatment and prevention. Annual Review of Medicine, 70, 137–150. https://doi.org/10.1146/annurev-med-041217-013717
Hunger, J. D., & Wheelen, T. L. (2011). Essentials of Strategic Management. Pearson Education, Inc.
Kamel, H. (2019). The AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenic stroke randomized trial: Rationale and methods. International Journal of Stroke, 14(2), 207–214. https://doi.org/10.1177/1747493018799981
Kasita, I. D., & Sudarmo, S. (n.d.). Collaborative Governance dalam Mengatasi Penyalahgunaan Narkoba di Kota Surakarta. Jurnal Mahasiswa Wacana Publik, 3(1), 119–135.
Khandia, R. (2019). A comprehensive review of autophagy and its various roles in infectious, non-infectious, and lifestyle diseases: Current knowledge and prospects for disease prevention, novel drug design, and therapy. Cells, 8(7). https://doi.org/10.3390/cells8070674
Kou, L. (2020). Therapeutic options and drug delivery strategies for the prevention of intrauterine adhesions. Journal of Controlled Release, 318, 25–37. https://doi.org/10.1016/j.jconrel.2019.12.007
Li, L. (2018). A Broad-Spectrum ROS-Eliminating Material for Prevention of Inflammation and Drug-Induced Organ Toxicity. Advanced Science, 5(10). https://doi.org/10.1002/advs.201800781
Nugrahani, F., & Hum, M. (2014). Metode Penelitian Kualitatif (Vol. 1, Issue 1). Cakra Books.
Nurlaelah, N., Harakan, A., & Mone, A. (2019). Strategi Badan Narkotika Nasional (BNN) Dalam Mencegah Peredaran Narkotika di Kota Makassar. Gorontalo Journal of Government and Political Studies, 2(1), 24–31.
Öblom, H. (2019). 3D-Printed Isoniazid Tablets for the Treatment and Prevention of Tuberculosis—Personalized Dosing and Drug Release. AAPS PharmSciTech, 20(2). https://doi.org/10.1208/s12249-018-1233-7
Pan, C. (2018). Coatings as the useful drug delivery system for the prevention of implant-related infections. Journal of Orthopaedic Surgery and Research, 13(1). https://doi.org/10.1186/s13018-018-0930-y
Patti, G. (2019). Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs. Nature Reviews Cardiology, 16(2), 113–130. https://doi.org/10.1038/s41569-018-0080-2
Saag, M. S. (2018). Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2018 recommendations of the international antiviral society-USA panel. JAMA - Journal of the American Medical Association, 320(4), 379–396. https://doi.org/10.1001/jama.2018.8431
Saag, M. S. (2020). Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2020 Recommendations of the International Antiviral Society-USA Panel. JAMA - Journal of the American Medical Association, 324(16), 1651–1669. https://doi.org/10.1001/jama.2020.17025
Sargiacomo, C. (2020). COVID-19 and chronological aging: Senolytics and other anti-aging drugs for the treatment or prevention of corona virus infection? Aging, 12(8), 6511–6517. https://doi.org/10.18632/AGING.103001
Scally, B. (2018). Effects of gastroprotectant drugs for the prevention and treatment of peptic ulcer disease and its complications: a meta-analysis of randomised trials. The Lancet Gastroenterology and Hepatology, 3(4), 231–241. https://doi.org/10.1016/S2468-1253(18)30037-2
Sugiyono, D. (2013). Metode Penelitian Pendidikan Pendekatan Kuantitatif, Kualitatif dan R&D.
Utami, D. R. (n.d.). Collaborative Governance Dalam Pengendalian Narkoba Antara Badan Narkotika Nasional Provinsi Jawa Timur Dengan Lembaga Swadaya Masyarakat.
Wahyu, Y. F. D. (2022). Strategi Dalam Pencegahan Penyalahgunaan Narkoba Pada Kalangan Remaja Oleh Badan Narkotika Nasional Kabupaten (BNNK) Temanggung. Journal of Politic and Government Studies, 11(2), 475–486.
Wong, R. S. Y. (2019). Role of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in Cancer Prevention and Cancer Promotion. Advances in Pharmacological Sciences, 2019. https://doi.org/10.1155/2019/3418975
Wu, H. (2018). Drug-induced nephrotoxicity: Pathogenic mechanisms, biomarkers and prevention strategies. Current Drug Metabolism, 19(7), 559–567. https://doi.org/10.2174/1389200218666171108154419
Zi, F. (2018). Metformin and cancer: An existing drug for cancer prevention and therapy (review). Oncology Letters, 15(1), 683–690. https://doi.org/10.3892/ol.2017.7412
Downloads
Published
How to Cite
License
Copyright (c) 2023 Erinda Tri Hernanda, Putri Robiatul Adawiyah
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
